Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 05 - 03 save search
Merus Announces First Patient Treated in Phase 1/2 Clinical Trial of MCLA-129 in Advanced Lung Cancer and Other Solid TumorsMerus’ Fourth Sponsored Bispecific Antibody Currently in Clinical Trials
Published: 2021-05-03 (Crawled : 21:00) - biospace.com/
MRUS | $40.35 -2.23% -2.28% 820K
|
Health Technology
|
| O: -0.29%
H: 9.87%
C: 9.1%
lung cancer solid tumors clinical trials phase 1 cancer antibody trial phase 3
Cerence to Present at the 2021 Wells Fargo Securities Virtual Industrials Conference
Published: 2021-05-03 (Crawled : 21:00) - globenewswire.com
CRNC | $11.275 -6.9% -7.41% 510K
|
Technology Services
|
| O: -1.73%
H: 2.15%
C: -1.88%
trial conference
Zealand Pharma announces publication of Phase 3 trial evaluating efficacy and safety of dasiglucagon for treatment of severe hypoglycemia in adult patients with diabetes
Published: 2021-05-03 (Crawled : 18:00) - biospace.com/
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: 0.55%
H: 1.25%
C: -0.69%
diabetes treatment hypoglycemia phase 3 trial
Mueller Water Products to Participate in the Oppenheimer 16th Annual Industrial Conference
Published: 2021-05-03 (Crawled : 16:00) - globenewswire.com
MWA | $15.41 1.72% 0.0% 1.8M
|
Producer Manufacturing
|
| O: 1.18%
H: 1.03%
C: -0.21%
trial conference
Regulus Therapeutics Announces Top-Line Data from the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
RGLS | $2.56 -7.91% -8.59% 450K
|
Health Technology
|
| O: -2.16%
H: 2.18%
C: -17.65%
disease treatment phase 1 trial topline phase 1b kidney phase 2b
AGTC Clinical Investigators Provide Encore Presentation of Data from the Company’s Ongoing XLRP and Achromatopsia Phase 1/2 Trials
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 3.66%
H: 0.11%
C: -6.04%
presentation ongoing phase 1 trial phase 3 phase 2
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
Published: 2021-05-03 (Crawled : 12:57) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 0.66%
H: 0.54%
C: -18.19%
covid expansion vaccine phase 3 trial covid-19
Meritor Announces Appointment of Jim Keane as Vice President of Industrial
Published: 2021-05-03 (Crawled : 12:15) - prnewswire.com
MTOR | $36.5 -0.03%
|
Producer Manufacturing
|
| O: 1.92%
H: 0.83%
C: -1.67%
trial
Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product
Published: 2021-05-03 (Crawled : 12:15) - globenewswire.com
GHSI | $7.89 0.62% 3.3K
|
Health Services
|
| O: 0.0%
H: 1.19%
C: 0.0%
trial health
Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-6306, a First-in-Class, Selective, Oral Inhibitor of PKMYT1
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
RPTX 4 | $3.34 -3.75% -3.89% 85K
|
Health Technology
|
| O: -0.52%
H: 1.75%
C: 0.4%
phase 1 trial phase 3 phase 2
Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes™ Trial
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
CABA | $16.3 0.74% 0.74% 650K
|
Health Technology
|
| O: 1.71%
H: 2.56%
C: -5.3%
trial
Johnson Controls to present at the Goldman Sachs Industrials & Materials Conference 2021
Published: 2021-05-03 (Crawled : 11:00) - prnewswire.com
JCI F | $64.23 -0.26% 0.0% 3.6M
|
Producer Manufacturing
|
| O: 1.01%
H: 1.78%
C: 1.46%
trial conference
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.